New data confirm longterm efficacy and safety of Crohn's disease therapy
Japans Takeda Pharmaceutical and Belgian biopharma company TiGenix have released new data from their
View ArticleJanssen releases twoyear data from Phase III Crohn's disease study
Janssen has announced new twoyear results from its longterm study evaluating the efficacy and safety
View ArticleRemission Noted After 2 Years for Patients with Crohns Disease
NewsNew data shows Stelara ustekinumab maintained clinical response and remission after two years of treatment in patients with moderate to severe Crohns disease.
View ArticleRedHill Biopharma Ltd RDHL Financial and Strategic SWOT Analysis Review...
SummaryRedHill Biopharma Ltd RedHill is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs for the treatment of inflammatory and gastrointestinal...
View ArticlePositive data on Remicade biosimilar in Crohns disease
South Korean biopharmaceutical firm Celltrion has presented the primary outcome from its pivotal randomized
View ArticleCrohn's Colitis Increase Risk for Acute Arterial Events
Ischemic events and stroke are significantly more frequent in patients with inflammatory bowel disease than in the general population according to a large French study. Medscape Medical News
View ArticleNew Data in Crohns Disease Patients Shows Similar Efficacy and Safety...
Dateline City NEW YORK Pfizer in partnership with Celltrion Healthcare presents new data for INFLECTRA in Crohns disease NEW YO...
View ArticleFiveYear OpenLabel Prospective Study Data Presented at the 12th Congress of...
About Ulcerative Colitis and Crohn’s Disease Ulcerative colitis UC and Crohn’s disease CD are marked by inflammation in the GI tract. UC impacts the large intestine only which...
View ArticleClinical Data from Phase 1 DoseEscalation Study of SingleAgent NKTR214 in...
SAN FRANCISCO and ORLANDO Fla. Feb. 18 2017 PRNewswire Nektar Therapeutics Nasdaq NKTR today announced that positive Phase 1 clinical data for Nektar's lead immunooncology agent NKTR214 in patients...
View ArticleTakeda et TiGenix prsentent de nouvelles donnes mettant en vidence le...
TiGenix &8212; Friday February 17th 2017 at 801am UTC COMMUNIQU DE PRESSE Takeda et TiGenix prsentent de nouvelles donnes mettant en vidence le maintien d&8217;une rmission long terme des...
View ArticleGalapagos NV GLPG Financial and Strategic SWOT Analysis Review Updated...
SummaryGalapagos NV Galapagos is a clinical stage biotechnology company that discovers and develops pharmaceutical products. The company's product pipeline encompasses investigational candidates...
View ArticleTiGenix hires Lonza to make cell therapy for Crohn's disease complications
TiGenix is using Lonza as a US CMO and Takeda as an exUS commercialization partner to launch and trial its offtheshelf stem cell therapy for a complication of Crohns disease.
View ArticleMycenax Biotech Inc 4726 Financial and Strategic SWOT Analysis Review Updated...
SummaryMycenax Biotech Inc Mycenax develops and manufactures pharmaceutical formulations. The company's pipeline portfolio encompasses investigational candidates targeted at the treatment of plaque...
View ArticleR3 Stem Cell Now Offering Regenerative Medicine Treatment in Las Vegas and...
R3 Stem Cell is now offering regenerative medicine treatment in Las Vegas and Henderson Nevada. Treatments have helped many patients avoid surgery and improve their lives dramatically.Las Vegas Nevada...
View ArticleBiosimilar Inflectra matches Remicade efficacy in trial
Pfizer and Celltrion have unveiled Phase III study data comparable safety and efficacy between biosmilar Inflectra and reference drug Remicade in patients with moderatetosevere Crohn's disease CD.
View ArticlePfizers Remicade biosimilar receives Crohn's trial boost
Inflectra shown to be similar to originator in data presented at ECCO in Barcelona
View ArticleImmunomodulators Azathioprine6Mercaptopurine and Methotrexate
Treatment aims in the inflammatory bowel diseases are evolving beyond the induction and maintenance of corticosteroidfree remission. More recently it has become recognized that by treating with...
View ArticleFIBROMYALGIE Le rgime alimentaire peutil changer la donne Pain and Therapy
Il existe peu d'études portant sur la capacité d'un régime alimentaire spécifique à soulager les symptômes de la fibromyalgie. Quelques...
View Article